Why the study?
Does a delayed PCI pharmacoinvasive strategy beyond 24 h improve outcomes in patients with ST-elevation myocardial infarction who have been timely thrombolyzed?
Does a delayed PCI pharmacoinvasive strategy beyond 24 h improve outcomes in patients with ST-elevation myocardial infarction who have been timely thrombolyzed?
Answers are grounded in this paper and cite their sources.
Delayed pharmacoinvasive PCI beyond 24 hours may be a reasonable strategy for STEMI patients with timely thrombolysis and non-occluded arteries.
Delayed PCI pharmacoinvasive strategy in a critical diseased but not completely occluded artery beyond 24 h in patients who have been timely thrombolyzed seems a reasonable strategy.
No takes yet. Share an insight, caveat, or question.
Sethi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: